As artificial intelligence (AI) gets more deeply embedded into the drug discovery systems of global pharma majors, an increasing number of use cases continue to emerge, some with the potential to shake the very foundations of how things have traditionally been done and others with more peripheral applications.
Generative AI In Drug Discovery And India’s Potential To Leapfrog
Heads of Novartis Biomedical, World Economic Forum and Indian majors like Sun Pharma’s SPARC, among others, discuss generative AI in drug discovery along with pointers for India to leapfrog the R&D process
